Micro Emerging Active

CGEN stock up 135% faces $44M trim by Kynam Capital

评分
0.3
动能
▲ 0.0
文章
2
来源
1

摘要

如果一篇报道讨论了机构对CG Oncology的持股变动，则该报道属于这个叙事。

相关文章

This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight …

Nasdaq · 三月 22, 2026
Mixed

This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should …

Nasdaq · 三月 21, 2026
Mixed

来源

This Biotech Stock Winner Is Up 72%, but a $4 … Nasdaq
This Biotech Stock Up 135% Just Faced a $44 Million … Nasdaq

时间线

最后更新 三月 21, 2026